This month's Research Ethics Roundup covers the latest in right-to-try, social media data access, FDA extrapolation of drug indications, return…
Read MoreThe COVID-19 pandemic has brought many issues to the public’s attention that used to be of interest only to clinical…
Read MoreMeet Jaime O’Brien, MS (Bioethics), who'll be covering the 2019 Advancing Ethical Research Conference (AER19) as a member of the Blog…
Read MoreExpanded access, which is treatment access to experimental drugs (also referred to as "compassionate use" or "pre-approval access"), has generated…
Read MoreOn May 30, 2018, the four-year Right to Try (RTT) movement culminated in a new federal law, with the stated…
Read More